Japan · 
Who invested in Cyto-Facto?
Cyto-Facto's investors include SMBC Venture Capital, Mizuho Capital and Mitsubishi Corporation.
Japan · Series A startup
Who invested in Cyto-Facto
One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Cyto-Facto and see its new rounds in your feed.Start following
Funding summaryUpdated 27 Oct 2026
$7.6Mraised across 1 round since 2024, from 1 source
- Latest round
- Series A, $7.6MApr 2024
- Investors
- 3
The rounds
- Apr 2024
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Cyto-Facto
How much has Cyto-Facto raised?
Cyto-Facto has raised $7.6M across 1 round since 2024.
When did Cyto-Facto last raise?
Cyto-Facto's most recent round was a Series A of $7.6M in Apr 2024.
What was Cyto-Facto's biggest round?
Its most recent round, $7.6M in Apr 2024, is also its largest on record.
Who backed Cyto-Facto first?
Cyto-Facto's first round on record, in Apr 2024, was backed by SMBC Venture Capital, Mizuho Capital and Mitsubishi Corporation.
What stage is Cyto-Facto at?
Cyto-Facto's latest named round is a Series A, in Apr 2024.
Where is Cyto-Facto based?
Cyto-Facto is based in Japan.
Companies like Cyto-Facto
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.